| HOME >> BIOLOGY >> TECHNOLOGY |
Other accrued expenses 4,977 4,014
Income tax payable 13,957 846
Deferred revenue - short term 2,957 2,836
Total current liabilities 54,765 40,470
Non-current income tax payable 4,341 3,958
Deferred income tax - long term 75 75
Deferred revenue - long term 4,441 4,607
Deferred rent - 10
Deferred compensation plan liabilities 2,348 1,893
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.0001 par value per share,
20,000,000 shares authorized, none issued and
outstanding - -
Common stock, $.0001 par value per share;
200,000,000 shares authorized, 53,992,269 and
53,916,298 shares issued and outstanding at
March 31, 2008 and December 31, 2007, respectively 5 5
Additional paid-in capital 423,452 415,229
Accumulated other comprehensive income 2,974 1,604
Retained earnings 353,147 321,202
Total stockholders' equity 779,578 738,040
Total liabilities and stockholders' equity $845,548 $789,053
Gen-Probe Incorporated
Consolidated Statements of Income
(In thousands, except per share data)
Three Months Ended
March 31,
'/>"/>
| SOURCE Gen-Probe Incorporated Copyright©2008 PR Newswire. All rights reserved |